Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
National Institutes of Health · Department of Health and Human Services
At a glance
Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed) is a forecasted federal cooperative agreement opportunity from the National Institutes of Health (Department of Health and Human Services). The agency's forecast estimates an application due date of October 1, 2026; forecast dates can change. Total estimated funding is $700K across about 1 awards. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 9 more. Cost sharing is not required. It is funded under Assistance Listing 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Sep 22, 2025Forecast posted
- Jul 1, 2026 (est.)Full notice expected
- Oct 1, 2026 (est.)Application deadline
- Jul 1, 2027 (est.)Est. award datenext date
- Posted
- Sep 22, 2025
- Est. close date
- Oct 1, 2026
- Est. award date
- Jul 1, 2027
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- $700,000
- Implied average award
- $700,000 calculated
- Expected awards
- 1
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
- Fiscal year
- FY2027
Typical awards for this program (SAM.gov listing for ALN 93.847, not this notice): Project Grants: Range of $1,300 to $10,834,000; $418,000 average NRSAs: Range of $2,500 to $869,000; $116,000 average SBIR: Range of $6,500 to $2,074,000; $585,000 average
Implied average = estimated total funding ÷ expected number of awards, calculated by GrantsJunction. Actual awards vary.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public colleges & universities
- Federally recognized tribal governments
- Public & Indian housing authorities
- Native American tribal organizations
- 501(c)(3) nonprofits
- Private colleges & universities
- For-profit organizations (not small businesses)
- Small businesses
- Others (see notice)
Additional information on eligibility (from the notice)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
- Nonprofits without 501(c)(3) status
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
The NIDDK, intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on collecting and analyzing data from clinical trials involving isolated human islets as a treatment for diabetes. This data will be used by research community for publications and presentations and to help design future clinical trials. Additionally, CITR will prepare periodic reports summarizing islet transplantation outcomes and trends overs time to inform the public. Additionally, CITR will conduct periodic meetings of the contributing sites. Applications are not being solicited currently. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the {U01 Clinical Trial Not Allowed Cooperative Agreement} activity code. Investigators with expertise and insights into this area of {Clinical Trial Data Collection} are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations combining expertise in {Data Analyses} will be encouraged and these investigators should also begin considering applying for this NOFO.
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 93.847
Historical data · not a predictionAgency contact (as published)
Thomas L. Eggerman
eggermant@extra.niddk.nih.gov
301-594-8813
Quick answers
Is this opportunity open for applications yet?
Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around July 1, 2026. Forecast details and dates can change.
Who is eligible to apply for this opportunity?
The official notice names these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Private colleges & universities, For-profit organizations (not small businesses) and 2 more. Additional restrictions may apply; review the full notice.
How much funding is available through this opportunity?
Per the notice, total estimated program funding is $700,000 and the agency expects to make about 1 awards.
How do I apply for this opportunity?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-DK-27-106), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
Rigor and Reproducibility for Biomarkers in Type 1 Diabetes Clinical Research
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jun 25, 2026 (est.)
- Who can apply
- State governments, County governments, Special district governments and 11 more
Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jul 1, 2026 (est.)
- Who can apply
- Others (see notice)
Single Source: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium- Renal and Environmental Science Core (U01-Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Jul 1, 2026 (est.)
- Who can apply
- State governments, County governments, Special district governments and 9 more
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health- Award range
- Up to $1M
- Closes
- Oct 9, 2026
- Who can apply
- State governments, County governments, City or township governments and 12 more
The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Nov 1, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 11 more
The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Nov 1, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 11 more